Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer

scientific article published in January 2007

Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000112945
P8608Fatcat IDrelease_qbrudnrzpba5jlbbvnvoscmtii
P698PubMed publication ID18176087

P2093author name stringMorito Monden
Makoto Yamasaki
Shuji Takiguchi
Yuichiro Doki
Hiroshi Miyata
Yoshiyuki Fujiwara
Junya Fujita
Ryohei Kawabata
Yasuo Tsukahara
P2860cites workPhase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancerQ46683166
Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).Q46685954
Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancerQ46828997
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.Q53604465
An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.Q54127938
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaQ27860904
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerQ33488159
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancerQ34366342
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study GroupQ34572233
Paclitaxel (taxol)Q34723890
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).Q35134370
Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitroQ36136024
Taxol stabilizes microtubules in mouse fibroblast cellsQ36360499
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinomaQ36381830
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancerQ36612612
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancerQ36673543
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactionsQ43754196
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.Q46658481
P433issue3-4
P921main subjectpaclitaxelQ423762
P304page(s)219-225
P577publication date2007-01-01
P1433published inOncologyQ2016300
P1476titlePhase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
P478volume72

Reverse relations

cites work (P2860)
Q42915841Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer
Q37534441Paclitaxel chemotherapy for the treatment of gastric cancer
Q44441494Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer

Search more.